Carlsson S R, Stigbrand T, Boquist L, Lundgren E, Winblad B, Larsson S E
Clin Orthop Relat Res. 1981 Sep(159):279-85.
Normal and thymectomized CBA mice treated with and without thymosin were injected with 2 x 10(6) viable osteosarcoma cells. The activity and weight of tumors, the cell-mediated and humoral-immune responses against the tumors, and the light microscopic characteristics suggested that thymectomy resulted in a significantly decreased tumor frequency. There were also significant increases in cell-mediated cytotoxic activity in vitro as measured by lysis of 51Cr-labeled tumor cells incubated with spleen cells, and in lymphocytic infiltration around the tumors. While thymosin treatment of thymectomized mice restored these parameters to those of intact animals, thymosin had no demonstrable effects on nonthymectomized animals.
对正常和经胸腺切除的CBA小鼠,分别给予和不给予胸腺素处理后,注射2×10⁶个活的骨肉瘤细胞。肿瘤的活性和重量、针对肿瘤的细胞介导免疫和体液免疫反应以及光镜特征表明,胸腺切除导致肿瘤发生率显著降低。通过用脾细胞孵育51Cr标记的肿瘤细胞的裂解来测量,体外细胞介导的细胞毒性活性以及肿瘤周围的淋巴细胞浸润也显著增加。虽然对经胸腺切除的小鼠给予胸腺素治疗可使这些参数恢复到完整动物的水平,但胸腺素对未进行胸腺切除的动物没有明显影响。